Shaping Healthcare for Over 38 Years!

Since 1987, we have been combining science, advanced technology, and innovative therapies to improve lives.

With our expertise in Oncology, Hematology, Radiology, Rheumatology, and other therapeutic areas, we continue our production activities on a global scale, contributing to a healthier future through reliable and innovative solutions.

Domestic Investment Award in Oncology!

Our investments have been crowned with one of the industry’s most prestigious honors — the 'Domestic Investment Award in Oncology.' This award is a testament to how the steps we take towards contributing to human health are shaping not only today but also the future.

All Over The World

Delivering innovative, high value-added medicines that enhance patients’ quality of life worldwide,
we shape the future with sustainable solutions while leading the way in healthcare.

600+

Employees

100+

Countries of Operation

450+

Global Licenses

15m+

Unit Production

Milestones

1987

Onko & Koçsel was founded as a family-owned company.

1988

Oncology and Hematology portfolio established.

1995

Entered the vaccine market

2000

Expanded into new therapeutic areas (Rheumatology, Radiology, etc.)

2002

Began domestic manufacturing

2010

Construction of state-of-the-art manufacturing facilities began

2014

Turkish GMP approval for the manufacturing facilitys

2017

EU GMP and MHRA approval granted for all manufacturing lines

2022

First marketing authorization in Europe and Canadian GMP approval

2023

Entered the UK, Germany, and Scandinavian-Baltic markets